Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
28 January 2020 | Story Rulanzen Martin | Photo Pexels
Conference
At the meet-and-greet last night, were from left Prof Ruad Ganzevoort, Diversity Officer and Dean of Theology and Religion at VUA, Prof Francis Petersen and Dr Gene Block, Chancellor of UCLA.

The Unit for Institutional Change and Social Justice at the University of the Free State (UFS) is hosting a colloquium on Fragility and Resilience: Facets, Features and Transformation in Higher Education which started on 29 January, with the official progamme concluding on 30 January 2020.

The colloquium is a annual collaborative partnership between the UFS, University of California, Los Angeles (UCLA), and the Vrije Universiteit Amsterdam (VUA).

Apart from the overarching themes the colloquium also placed some focus on mental health, within this context as all three regions are witnessing a spike in mental health issues among students and staff as well as a deficit in terms of being able to sufficiently address the crisis.

“All three universities are committed to discussing global developments in diversity and transformation in higher education to discussing global developments in diversity and transformation as it may constitute itself in higher education circles around the globe,” says Dr Dionne van Reenen, convener of the 2020 colloquium and research fellow at the unit.  

The idea is to discuss what has and has not worked and, hopefully, access best practices in a variety of contexts. The partnership between the three universities spans over six years starting in 2014 when the UFS first hosted the research colloquium. It is the third time the UFS has hosted the colloquium.
 
Prof Francis Petersen, Rector and Vice-Chancellor of the UFS, along with other members of the UFS Rectorate, attended a meet-and-greet on Monday 28 January 2020, and was joined by Dr Gene Block, Chancellor of UCLA, Vice Provosts Cindy Fan, Patricia Turner, Charles Alexander, Professors Abel Valenzuela, John Hamilton and Dr Shalom Staub, director of Community Learning, as well as Prof Ruard Ganzevoort, Chief Diversity Officer and Dean of Theology and Religion at VUA 

News Archive

Collaboration between UFS and Mayo Clinic to revolutionise cancer treatment
2014-06-27



Attending the lecture were, from the left: Dr Chantel Swart, Prof Lodewyk Kock, Prof Debabrata Mukhopadhyay, Prof James du Preez; back: Prof Pieter van Wyk.
Dr Swart, Profs Kock and Du Preez are from the Department of Microbial, Biochemical and Food Biotechnology. Prof Mukhopadhyay is from the Mayo Clinic (US) and Prof Van Wyk is from the Centre for Microscopy at the UFS.
Photo: Supplied
The UFS made a discovery that may have enormous implications for the treatment of diseases in humans.

Since the discovery, the UFS joined forces with the Mayo Clinic in Rochester, US, in the fight against cancer.

In this collective effort, UFS researchers would be able to assist the Mayo team to:
• see how treatment in cancer patients is progressing,
• target treatments more effectively,
• reduce dosages in order to make treatment gentler on the patient,
• track the effectiveness of the chemotherapy drugs used, and
• gain an accurate view of how the cancer is being eliminated.

Prof Lodewyk Kock, Outstanding Professor at the Department of Microbial, Biochemical and Food Biotechnology, and his team incidentally created a technique to use argon gas particles for the first time on biological material to slice open cells to look inside.

The team that supported Prof Kock includes Dr Chantel Swart, Khumisho Dithebe (PhD student), Prof Hendrik Swart (Department of Physics) and Prof Pieter van Wyk (Centre for Microscopy).

Prof Debabrata Mukhopadhyay from the Mayo Clinic in Rochester, US, got to hear about this breakthrough at the UFS and a collaboration between the two institutions was established.

During a visit to the Bloemfontein Campus, Prof Mukhopadhyay explained novel techniques that make use of gold nanoparticles. These particles attach to chemotherapeutic drugs to selectively target cancer cells – dramatically decreasing the side effects to normal human cells.

For these new drugs (coupled to gold nanoparticles) to be accepted into clinical practice, visual and chemical proof is needed, though. This is where the technique developed by the UFS will play a vital role.

With the technique to look inside cells, the composition, location and metabolism of these drugs can be determined. This will aid in a proof of concept for the application of the nano-drugs. Furthermore, it will enable approval for use of these drugs in clinical trials and eventually could revolutionise cancer treatment as a whole.

For video lectures on the technique used, as well as its findings, follow these links:

1. http://vimeo.com/63643628 (Comic version for school kids)

2. http://vimeo.com/61521401 (Detailed version for fellow scientists)

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept